Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.
Allogene Therapeutics Inc Is A Clinical Stage Immuno-Oncology Company Pioneering The Development Of Genetically Engineered Allogeneic T Cell Product Candidates For The Treatment Of Cancer And Autoimmune Diseases. Its Pipeline Includes "Off-The-Shelf" T Cell Candidates Designed To Target Cancer Cells Or Eliminate Autoreactive Cells In Patients With Autoimmune Disorders. Its Three Core Programs Are: Large B-Cell Lymphoma (Lbcl), Autoimmune Disease (Aid) And Renal Cell Carcinoma (Rcc).